{"hq_id":"hq-c-org-001938","name":"Daidzein","context":"human_adult","risk_level":"low","schema":"legacy","note":"Synthesis unavailable: compound lacks vectorizable regulatory classifications. Raw safety data returned.","data":{"risk_level":"low","summary":"Second major soy isoflavone; weaker ER binding than genistein. Metabolized to equol by gut bacteria (~30-50% of Western adults). Equol producers may have enhanced estrogenic/anti-estrogenic effects."},"meta":{"synthesis_version":"n/a","timestamp":"2026-10-28T20:54:22.957Z"},"_notice":"ALETHEIA output is reference data, not professional advice. Not a substitute for primary agency sources or qualified professionals. See https://aletheia.holisticquality.io/disclaimer.","_disclaimer_url":"https://aletheia.holisticquality.io/disclaimer","available_contexts":["human_adult","human_child","dog","aquatic_life","human_teen","human_elderly","human_infant","human_pregnant"]}